Drugs Controller General of India

Abbott’s Once-A-Day Ivabradine Receives DCGI Approval for Heart Failure and Angina patients

Zenara Pharma receives DCGI approval to manufacture and sell Favipiravir tablets – Favizen

The Drugs Controller General of India approves Phase II+III trials of Oxford University vaccine 

Health Ministry on H1N1: Closely monitoring the situation; no shortage of drugs

The Indian pharmaceutical industry stands with the full support of the Government of India : Commerce Secretary